Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 55Neoplasms, Plasma Cell 22Central Nervous System Neoplasms 10Prostatic Neoplasms 9Glioblastoma 9Recurrence 8Melanoma 8Brain Neoplasms 8Neoplasms 7Gliosarcoma 7Carcinoma, Non-Small-Cell Lung 7Sarcoma 6Leukemia 6Carcinoma, Hepatocellular 6Waldenstrom Macroglobulinemia 5Myeloproliferative Disorders 5Lung Neoplasms 5Leukemia, Lymphocytic, Chronic, B-Cell 5Glioma 5Colorectal Neoplasms 5Myelodysplastic-Myeloproliferative Diseases 4Myelodysplastic Syndromes 4Lymphoma 4Liver Neoplasms 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Kidney Neoplasms 4Carcinoma, Renal Cell 4Lymphoma, Mantle-Cell 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Chronic 3

Interventions

Paclitaxel 2nirogacestat 1halofuginone 1etoposide phosphate 1Thalidomide 1Sunitinib 1Semaxinib 1Saquinavir 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Nelfinavir 1Interleukin-12 Subunit p35 1Indinavir 1Imatinib Mesylate 1Ifosfamide 1Filgrastim 1Etoposide 1Cidofovir 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × AIDS-related Kaposi sarcoma × Thalidomide × Clear all
NCT00019123 2013-08-16

Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡